Bendicio, Kyle N.

HRN: 26-06-78  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2026
MUPIROCIN 2%, 15G (TUBE)
05/23/2026
05/27/2026
TOOPICAL
Apply Thinly On Affected Areas
Bid
Infected Lesions
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines